Nanologica has recruited Dr. PK Dutta as SVP Sales and Senior Advisor for the business area of chromatography. Dr. PK Dutta will focus on sales growth of Nanologica’s chromatography products primarily in the US. To accelerate sales of chromatography products following the successful upscaling of Nanologica’s silica towards ton scale, Dr. Dutta has been recruited as SVP Sales and Senior Advisor. The position includes leading efforts and strategy for market growth in direct and indirect
Category: Other press releases
Nanologica har rekryterat Dr. PK Dutta till positionen som SVP Sales and Senior Advisor för affärsområdet kromatografi. Dr. PK Dutta kommer att fokusera på försäljningstillväxt av Nanologicas produkter för kromatografi primärt i USA. För att accelerera försäljningen av kromatografiprodukter, efter den lyckade uppskalningen av Nanologicas silikaproduktion till tonskala, har Dr. Dutta rekryterats som SVP Sales and Senior Advisor. Rollen innefattar att sätta strategier för tillväxt, samt leda direkt och indirekt försäljning med fokus på Nordamerika.
A collaboration agreement for the use of the NLAB drug delivery platforms has been signed with Zentiva, a pharmaceutical company operating in Europe and beyond. The aim of this collaboration agreement is to simplify the contract process for future product-specific agreements. The agreement gives Zentiva the right to use the NLAB drug delivery platforms for multiple drug development projects. Project specific agreements will be signed separately under this collaboration agreement. ” We first met Zentiva
The first batch of test material from the large-scale production of Nanologica AB’s silica has been approved. The quality of the material produced at the CMO Sterling Pharma Solutions in the UK is identical to the material produced at Nanologica’s plant in Södertälje. In December 2020, the first batch of test material from the upscaling to large-scale production of Nanologica’s silica was delivered. Rigorous quality testing of the silica now confirms identical quality to the
Nanologica AB has engaged two senior scientific advisors within the field of respiratory drug delivery, for the purpose of advancing the NLAB Spiro™ inhalation platform further. Dr. John Pritchard has more than 40 years of experience from the inhalation industry working in various positions, leading and managing global portfolios of technology projects from discovery to market, at for example GlaxoSmithKline, 3M Health Care Ltd and as Head of Respiratory Project Management at AstraZeneca. His vast
The first samples of test material from the upscaling to large-scale production of Nanologica’s silica have been delivered. Upscaling to large-scale production of Nanologica’s silica started in July 2019. The silica is produced according to Nanologica’s proprietary methods at the contract manufacturer Sterling Pharma Solutions in the UK. The first samples of test material have now been delivered. ” It is very pleasing to having received the first test material from the large-scale production. This